Innovation requires collaboration. None of us can do it all ourselves. Companies that have embraced open innovation are looking outside their walls for new ideas. These companies are seeking out ...
LifeScan (the "Company"), a world leader in blood glucose monitoring, today announced its successful emergence from its Chapter 11 financial restructuring process following approval of its Plan of ...
LOS ANGELES, Oct. 02, 2018 (GLOBE NEWSWIRE) — Platinum Equity today announced that its acquisition of LifeScan from Johnson & Johnson (NYSE: JNJ) for approximately $2.1 billion has been completed, ...
Fitbit has partnered with diabetes tracking company LifeScan, offering users the chance to keep tabs on blood sugar trends within the Fitbit app. LifeScan offers cloud-based tracking of glucose levels ...
LifeScan ("the "Company"), a world leader in glucose monitoring, today announced a transformational partnership with i-SENS, a global biosensor specialist, to launch a continuous glucose monitoring ...
MALVERN, Pa. and SAN FRANCISCO, Aug. 10, 2021 /PRNewswire/ — LifeScan, a world leader in blood glucose monitoring serving more than 20 million people with diabetes, and Fitbit, today announced a ...
SAN FRANCISCO--(BUSINESS WIRE)--gA (Grupo Assa), a global leader in Digital Business Transformation, will be featured during Oracle® OpenWorld® 2018 as part of a case study outlining gA’s role in ...
MALVERN, Pa. and NEW YORK, Aug. 17, 2021 /PRNewswire/ — LifeScan, a world leader in blood glucose monitoring, serving more than 20 million people with diabetes and the maker of the iconic OneTouch (R) ...
LifeScan, a Johnson and Johnson company, just announced that its companion app, Reveal, for people with diabetes who use the OneTouch Verio Sync Meter, now enables data sharing with third party apps ...
In her new role, Ms. Rose will lead global marketing efforts and manage the innovation pipeline, commercialization of new digital health products and LifeSpan’s branding — including its OneTouch ...
Lifescan Inc., a maker of diabetes monitors, agreed to pay $45 million to diabetics in the United States to settle a class-action suit that claimed its products were dangerously defective. Lifescan, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results